anayamalik, Author at European Medical Journal - Page 116 of 120

New Score Predicts Clinical Outcomes in MAC Lung Disease: CHEST 2024

A new study has shown that the BACES score, a clinical tool used to predict mortality in non-tuberculous mycobacteria (NTM) lung disease, can also help predict treatment outcomes in patients with Mycobacterium avium complex lung disease (MAC-LD)

CDC Implements Marburg Virus Screening for U.S. Travelers

The CDC will screen U.S.-bound travelers from Rwanda starting October 14 due to a Marburg virus outbreak, which has resulted in 56 confirmed cases and 12 deaths

AI Breakthrough in Pulmonary Hypertension Diagnosis: CHEST 2024

Pulmonary hypertension is a progressive and potentially fatal condition that can go undetected until it reaches advanced stages. A groundbreaking study presented at the CHEST Annual Meeting 2024 introduces a multimodal fusion model (MMF-PH) that incorporates AI

Dupilumab for COPD Phase 3 Trial Results: CHEST 2024

Findings from two Phase 3 clinical trials, BOREAS and NOTUS, revealed that dupilumab, a monoclonal antibody targeting key drivers of type 2 inflammation, improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD)

Hurricane Milton Forces Florida Hospitals to Close

Hurrican Milton approaches Florida’s west coast as hospitals and healthcare centers across the state are closing in preparation for its potentially devastating impact

Understanding COPD Outcomes for Women in Rural America: CHEST 2024

A new study presented at the CHEST Annual Meeting 2024 highlights the growing disparity in mortality rates for women with chronic obstructive pulmonary disease (COPD), especially those in rural areas.

Idiopathic Pulmonary Fibrosis Hospitalizations Worsen Patient Outcomes: CHEST 2024

Hospital stays lead to worsening fatigue and shortness of breath in patients with idiopathic pulmonary fibrosis (IPF) according to a new study presented at the CHEST 2024 Annual Meeting.

New Antibody Target in Marburg Virus: Vaccine Potential

Marburg virus survivors have been investigated in a new study that has identified a key immunogen in the virus’s wing domain that could revolutionize vaccine development.

Digital Health Boosts Lung Cancer Screening Rates: CHEST 2024

A digital health program, mPATH-Lung, has been shown to significantly improves lung cancer screening (LCS) rates among high-risk individuals.

Transforming Palliative Care in Underserved Populations: CHEST 2024

A new study presented at the CHEST Annual Meeting 2024 highlighted the success of a new clinic aimed at improving palliative care access.